Does ALEMTUZUMAB Cause Diffuse large b-cell lymphoma? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Diffuse large b-cell lymphoma have been filed in association with ALEMTUZUMAB (Campath). This represents 0.4% of all adverse event reports for ALEMTUZUMAB.
56
Reports of Diffuse large b-cell lymphoma with ALEMTUZUMAB
0.4%
of all ALEMTUZUMAB reports
20
Deaths
36
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From ALEMTUZUMAB?
Of the 56 reports, 20 (35.7%) resulted in death, 36 (64.3%) required hospitalization, and 14 (25.0%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which ALEMTUZUMAB Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET